Development Path and Capital Structure of Belgian Biotechnology Firms
National Bank of Belgium Working Paper No. 30
56 Pages Posted: 16 Oct 2010
Date Written: May 1, 2002
Abstract
This study investigates the relationship between the evolution of real options values and associated financing policies for Belgian companies in the sector of bio-industries. Each firm's situation regarding the relevant types of real options is stylistically represented through a scenario tree. The consumption of a time-to-build or a growth option is respectively considered as a success or a failure in company development. Empirically, several variables enable us to locate each company along the tree at any time. The study of transitions leads us to discover that failures tend to trigger higher leverage, unlike in the trade-off theory. Yet, the increases in debt maturity, in lease and in convertible financing confirm our predictions. Overall, we emphasize evidence of undercapitalization and of proper, yet insufficient, use of hybrid financing by biotech companies.
Suggested Citation: Suggested Citation
Do you have negative results from your research you’d like to share?
Recommended Papers
-
Uncertainty and Investment Dynamics
By Nicholas Bloom, Stephen R. Bond, ...
-
The Differential Impact of Uncertainty on Investment in Small and Large Businesses
By Vivek Ghosal and Prakash Loungani
-
Uncertainty and Economic Activity: Evidence from Business Survey Data
By Ruediger Bachmann, Steffen Elstner, ...
-
Exploring the Role of Uncertainty for Corporate Investment Decisions in Germany
-
Uncertainty and Company Investment Dynamics: Empirical Evidence for UK Firms
By Nicholas Bloom, Stephen R. Bond, ...
-
Does Demand and Price Uncertainty Affect Belgian and Spanish Corporate Investment?
-
The Impact of Uncertainty on Investment Plans
By Paul Butzen, Catherine Fuss, ...
-
Firm-Specific Productivity Risk Over the Business Cycle: Facts and Aggregate Implications
By Ruediger Bachmann and Christian Bayer